FDA approves Sciele's new Sular formulation

01/2/2008 | Forbes

The FDA has approved all four dosage strengths of Sciele Pharma's new formulation for its Sular hypertension drug, the company announced Wednesday. Sciele intends to launch its new Sular formulation, which uses SkyePharma's Geomatrix technology, within the first quarter.

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN